首页> 外文期刊>biomolecules >The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
【24h】

The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions

机译:表观遗传修饰在人类癌症中的作用以及天然化合物作为表观药物的使用:机理途径和药效学作用

获取原文
获取外文期刊封面目录资料

摘要

Cancer is a complex disease resulting from the genetic and epigenetic disruption of normal cells. The mechanistic understanding of the pathways involved in tumor transformation has implicated a priori predominance of epigenetic perturbations and a posteriori genetic instability. In this work, we aimed to explain the mechanistic involvement of epigenetic pathways in the cancer process, as well as the abilities of natural bioactive compounds isolated from medicinal plants (flavonoids, phenolic acids, stilbenes, and ketones) to specifically target the epigenome of tumor cells. The molecular events leading to transformation, angiogenesis, and dissemination are often complex, stochastic, and take turns. On the other hand, the decisive advances in genomics, epigenomics, transcriptomics, and proteomics have allowed, in recent years, for the mechanistic decryption of the molecular pathways of the cancerization process. This could explain the possibility of specifically targeting this or that mechanism leading to cancerization. With the plasticity and flexibility of epigenetic modifications, some studies have started the pharmacological screening of natural substances against different epigenetic pathways (DNA methylation, histone acetylation, histone methylation, and chromatin remodeling) to restore the cellular memory lost during tumor transformation. These substances can inhibit DNMTs, modify chromatin remodeling, and adjust histone modifications in favor of pre-established cell identity by the differentiation program. Epidrugs are molecules that target the epigenome program and can therefore restore cell memory in cancerous diseases. Natural products isolated from medicinal plants such as flavonoids and phenolic acids have shown their ability to exhibit several actions on epigenetic modifiers, such as the inhibition of DNMT, HMT, and HAT. The mechanisms of these substances are specific and pleiotropic and can sometimes be stochastic, and their use as anticancer epidrugs is currently a remarkable avenue in the fight against human cancers.
机译:癌症是一种复杂的疾病,由正常细胞的遗传和表观遗传破坏引起。对肿瘤转化途径的机制理解意味着表观遗传扰动和后验遗传不稳定性的先验优势。在这项工作中,我们旨在解释表观遗传途径在癌症过程中的机制参与,以及从药用植物(类黄酮、酚酸、二苯乙烯和酮)中分离的天然生物活性化合物特异性靶向肿瘤细胞表观基因组的能力。导致转化、血管生成和播散的分子事件通常是复杂的、随机的,并且是轮流发生的。另一方面,近年来,基因组学、表观基因组学、转录组学和蛋白质组学的决定性进展使得对癌化过程的分子途径进行机械解密成为可能。这可以解释专门针对导致癌症化的这种或那种机制的可能性。随着表观遗传修饰的可塑性和灵活性,一些研究已经开始针对不同表观遗传途径(DNA甲基化、组蛋白乙酰化、组蛋白甲基化和染色质重塑)对天然物质进行药理学筛选,以恢复肿瘤转化过程中丢失的细胞记忆。这些物质可以抑制 DNMT,修饰染色质重塑,并调整组蛋白修饰,有利于通过分化程序预先建立的细胞身份。表观药物是靶向表观基因组程序的分子,因此可以恢复癌性疾病中的细胞记忆。从类黄酮和酚酸等药用植物中分离出的天然产物已显示出它们对表观遗传修饰剂表现出多种作用的能力,例如抑制 DNMT、HMT 和 HAT。这些物质的机制是特异性和多效性的,有时可能是随机的,它们作为抗癌药物的用途目前是对抗人类癌症的一个非凡的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号